#term ID	term description	observed gene count	background gene count	strength	false discovery rate	matching proteins in your network (IDs)	matching proteins in your network (labels)
WP4754	IL-18 signaling pathway	19	270	0.91	5.01e-09	9606.ENSP00000200676,9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000346148,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000385834,9606.ENSP00000401399,9606.ENSP00000402152,9606.ENSP00000474412,9606.ENSP00000477707,9606.ENSP00000478570	CETP,MAPK1,IFNG,HSPB1,TIMP3,MMP14,PRKAA1,CCL20,PTGS2,PTEN,NOX1,BMP2,BCL2,TF,MYD88,SLC12A3,CCL5,NR1H3,VEGFA
WP2431	Spinal cord injury	12	116	1.08	3.83e-07	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000377372,9606.ENSP00000383364,9606.ENSP00000400175,9606.ENSP00000414303	MAPK1,TGFB1,IFNG,SOX9,NOX4,CXCL10,CD47,PTGS2,GAP43,PLA2G2A,RHOA,BDNF
WP4172	PI3K-Akt signaling pathway	18	336	0.79	3.95e-07	9606.ENSP00000215832,9606.ENSP00000222139,9606.ENSP00000258341,9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346148,9606.ENSP00000346508,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	MAPK1,EPOR,LAMC1,THBS1,IGF1R,ANGPT2,PDGFB,PRKAA1,PDGFA,SGK1,PTEN,JAK2,PDGFD,BCL2,FGFR1,NTF3,BDNF,VEGFA
WP4806	EGFR tyrosine kinase inhibitor resistance	10	83	1.14	1.28e-06	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000331831,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,IGF1R,PDGFB,GAS6,PDGFA,PTEN,JAK2,PDGFD,BCL2,VEGFA
WP3888	VEGFA-VEGFR2 signaling pathway	18	428	0.68	8.41e-06	9606.ENSP00000215832,9606.ENSP00000216181,9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000301522,9606.ENSP00000306124,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000346148,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000368104,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000419313,9606.ENSP00000478570	MAPK1,MYH9,HSPB1,NOX4,PRDX2,PRKCE,MMP14,CAV1,PRKAA1,MAP3K5,PTGS2,TXN,BMP2,KL,BCL2,RHOA,TRPC1,VEGFA
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	11	143	0.95	1.10e-05	9606.ENSP00000215832,9606.ENSP00000257430,9606.ENSP00000311005,9606.ENSP00000341208,9606.ENSP00000346148,9606.ENSP00000358513,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000397297,9606.ENSP00000414303	MAPK1,APC,MAPK7,STAT5A,PRKAA1,CNR1,ALPL,BMP2,JAK2,NTF3,BDNF
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	15	302	0.76	1.10e-05	9606.ENSP00000215832,9606.ENSP00000222139,9606.ENSP00000258341,9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346148,9606.ENSP00000346508,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000478570	MAPK1,EPOR,LAMC1,THBS1,IGF1R,ANGPT2,PDGFB,PRKAA1,PDGFA,SREBF1,PTEN,JAK2,PDGFD,FGFR1,VEGFA
WP3624	Lung fibrosis	8	63	1.16	1.46e-05	9606.ENSP00000221930,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000474412,9606.ENSP00000478319	TGFB1,PDGFB,PDGFA,ELN,EDN1,NFE2L2,CCL5,GREM1
WP2324	AGE/RAGE pathway	8	66	1.14	1.80e-05	9606.ENSP00000215832,9606.ENSP00000308208,9606.ENSP00000341208,9606.ENSP00000363973,9606.ENSP00000371067,9606.ENSP00000390651,9606.ENSP00000400175,9606.ENSP00000401399	MAPK1,MMP14,STAT5A,ALPL,JAK2,IRAK4,RHOA,MYD88
WP306	Focal adhesion	12	196	0.85	1.80e-05	9606.ENSP00000215832,9606.ENSP00000258341,9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,LAMC1,THBS1,IGF1R,PDGFB,CAV1,PDGFA,PTEN,PDGFD,BCL2,RHOA,VEGFA
WP615	Senescence and autophagy in cancer	9	105	0.99	3.89e-05	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185	MAPK1,TGFB1,IFNG,THBS1,IGF1R,MMP14,PTEN,BMP2,BCL2
WP15	Selenium micronutrient network	8	86	1.03	8.61e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000301522,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000365777,9606.ENSP00000383232,9606.ENSP00000384906	MPO,IFNG,PRDX2,PTGS2,TXN,MTHFR,GGT1,SAA1
WP474	Endochondral ossification	7	62	1.11	0.00011	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000363973,9606.ENSP00000393312,9606.ENSP00000478570	TGFB1,SOX9,TIMP3,IGF1R,ALPL,FGFR1,VEGFA
WP4808	Endochondral ossification with skeletal dysplasias	7	62	1.11	0.00011	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000363973,9606.ENSP00000393312,9606.ENSP00000478570	TGFB1,SOX9,TIMP3,IGF1R,ALPL,FGFR1,VEGFA
WP4216	Chromosomal and microsatellite instability in colorectal cancer 	7	73	1.04	0.00026	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000257430,9606.ENSP00000288266,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000400175	MAPK1,TGFB1,APC,APPL1,PTGS2,BCL2,RHOA
WP2848	Pluripotent stem cell differentiation pathway	6	48	1.16	0.00029	9606.ENSP00000221930,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000355370,9606.ENSP00000385834,9606.ENSP00000478570	TGFB1,PDGFB,PDGFA,CNTF,TF,VEGFA
WP286	IL-3 signaling pathway	6	49	1.15	0.00030	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000228434,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185	MAPK1,TGFB1,CD69,STAT5A,JAK2,BCL2
WP4659	Gastrin signaling pathway	8	114	0.91	0.00040	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000306124,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,CDH1,PRKCE,PTGS2,BMP2,JAK2,RHOA,VEGFA
WP1544	MicroRNAs in cardiomyocyte hypertrophy	7	83	0.99	0.00045	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000311005,9606.ENSP00000368683,9606.ENSP00000383364,9606.ENSP00000400175	MAPK1,TGFB1,IGF1R,MAPK7,EDN1,PLA2G2A,RHOA
WP4298	Acute viral myocarditis	7	86	0.97	0.00054	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000381185	MAPK1,TGFB1,IFNG,CCR5,CAV1,EDN1,BCL2
WP5098	T-cell activation SARS-CoV-2	7	86	0.97	0.00054	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000354782,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000403495	MAPK1,IFNG,CD247,PTEN,JAK2,MYD88,LTA
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	4	16	1.46	0.00071	9606.ENSP00000337332,9606.ENSP00000346148,9606.ENSP00000348069,9606.ENSP00000477707	SIRT6,PRKAA1,SREBF1,NR1H3
WP236	Adipogenesis	8	130	0.85	0.00078	9606.ENSP00000221930,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000368104,9606.ENSP00000477707	TGFB1,PLIN1,LPL,EBF1,STAT5A,SREBF1,BMP2,NR1H3
WP2882	Nuclear receptors meta-pathway	12	316	0.64	0.00078	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000259407,9606.ENSP00000330382,9606.ENSP00000348069,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000383232,9606.ENSP00000477707	TGFB1,IFNG,BAAT,PDGFB,SREBF1,CCL20,PTGS2,TXN,G6PD,NFE2L2,GGT1,NR1H3
WP3915	Angiopoietin-like protein 8 regulatory pathway	8	130	0.85	0.00078	9606.ENSP00000215832,9606.ENSP00000309757,9606.ENSP00000311005,9606.ENSP00000346148,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000361883,9606.ENSP00000477707	MAPK1,LPL,MAPK7,PRKAA1,SREBF1,MAP3K5,CAP1,NR1H3
WP4673	Male infertility	8	141	0.81	0.0012	9606.ENSP00000013807,9606.ENSP00000222572,9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000363822,9606.ENSP00000365777,9606.ENSP00000380252,9606.ENSP00000381185	ERCC1,PON2,THBS1,ATM,AR,MTHFR,NFE2L2,BCL2
WP75	Toll-like receptor signaling pathway	7	103	0.89	0.0012	9606.ENSP00000215832,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412	MAPK1,CXCL10,CXCL11,CXCL9,IRAK4,MYD88,CCL5
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	6	71	0.99	0.0013	9606.ENSP00000215832,9606.ENSP00000216862,9606.ENSP00000229135,9606.ENSP00000306124,9606.ENSP00000311005,9606.ENSP00000339191	MAPK1,CYP24A1,IFNG,PRKCE,MAPK7,CAV1
WP4674	Head and neck squamous cell carcinoma	6	72	0.98	0.0013	9606.ENSP00000268035,9606.ENSP00000346148,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000478570	IGF1R,PRKAA1,PTEN,NFE2L2,FGFR1,VEGFA
WP716	Vitamin A and carotenoid metabolism	5	43	1.13	0.0013	9606.ENSP00000215832,9606.ENSP00000232219,9606.ENSP00000297785,9606.ENSP00000309757,9606.ENSP00000360522	MAPK1,RBP1,ALDH1A1,LPL,RBP4
WP2586	Aryl hydrocarbon receptor Netpath	5	46	1.1	0.0015	9606.ENSP00000215832,9606.ENSP00000309757,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000478570	MAPK1,LPL,PTGS2,NFE2L2,VEGFA
WP382	MAPK signaling pathway	10	245	0.67	0.0015	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000248553,9606.ENSP00000311005,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351908,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000414303	MAPK1,TGFB1,HSPB1,MAPK7,PDGFB,PDGFA,MAP3K5,FGFR1,NTF3,BDNF
WP3878	ATM signaling in development and disease 	5	45	1.11	0.0015	9606.ENSP00000248553,9606.ENSP00000278616,9606.ENSP00000346148,9606.ENSP00000351908,9606.ENSP00000377192	HSPB1,ATM,PRKAA1,MAP3K5,G6PD
WP4666	Hepatitis B infection	8	151	0.79	0.0015	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000341208,9606.ENSP00000363827,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399	MAPK1,TGFB1,STAT5A,HSPG2,JAK2,BCL2,IRAK4,MYD88
WP710	DNA damage response (only ATM dependent)	7	110	0.86	0.0015	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000257430,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175	MAPK1,TGFB1,APC,ATM,PTEN,BCL2,RHOA
WP1528	Physiological and pathological hypertrophy of the heart	4	24	1.28	0.0017	9606.ENSP00000215832,9606.ENSP00000306124,9606.ENSP00000368683,9606.ENSP00000400175	MAPK1,PRKCE,EDN1,RHOA
WP1539	Angiogenesis	4	24	1.28	0.0017	9606.ENSP00000215832,9606.ENSP00000266085,9606.ENSP00000330382,9606.ENSP00000478570	MAPK1,TIMP3,PDGFB,VEGFA
WP3931	Embryonic stem cell pluripotency pathways	7	116	0.84	0.0017	9606.ENSP00000215832,9606.ENSP00000257430,9606.ENSP00000311005,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000393312	MAPK1,APC,MAPK7,PDGFB,PDGFA,PTEN,FGFR1
WP481	Insulin signaling	8	159	0.76	0.0018	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000311005,9606.ENSP00000346148,9606.ENSP00000351908,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000361883	MAPK1,IGF1R,MAPK7,PRKAA1,MAP3K5,SGK1,PTEN,CAP1
WP1533	Vitamin B12 metabolism	5	50	1.06	0.0019	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000365777,9606.ENSP00000384906,9606.ENSP00000474412	MPO,IFNG,MTHFR,SAA1,CCL5
WP581	EPO receptor signaling	4	26	1.25	0.0020	9606.ENSP00000215832,9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000371067	MAPK1,EPOR,STAT5A,JAK2
WP2035	Follicle stimulating hormone (FSH) signaling pathway	4	27	1.23	0.0023	9606.ENSP00000215832,9606.ENSP00000288266,9606.ENSP00000356832,9606.ENSP00000414303	MAPK1,APPL1,SGK1,BDNF
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	4	28	1.22	0.0025	9606.ENSP00000221930,9606.ENSP00000305651,9606.ENSP00000390651,9606.ENSP00000474412	TGFB1,CXCL10,IRAK4,CCL5
WP2328	Allograft Rejection	6	89	0.89	0.0027	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000419422,9606.ENSP00000478570	TGFB1,IFNG,CXCL11,CXCL9,AGTR1,VEGFA
WP4969	RAS and bradykinin pathways in COVID-19	4	29	1.2	0.0027	9606.ENSP00000215832,9606.ENSP00000216862,9606.ENSP00000400175,9606.ENSP00000419422	MAPK1,CYP24A1,RHOA,AGTR1
WP366	TGF-beta signaling pathway	7	132	0.79	0.0030	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000285407,9606.ENSP00000339191,9606.ENSP00000339916,9606.ENSP00000400175	MAPK1,TGFB1,THBS1,KLF10,CAV1,LIMK2,RHOA
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	4	30	1.19	0.0030	9606.ENSP00000245479,9606.ENSP00000330382,9606.ENSP00000355370,9606.ENSP00000368104	SOX9,PDGFB,CNTF,BMP2
WP5102	Familial partial lipodystrophy (FPLD)	4	30	1.19	0.0030	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000348069	FABP4,PLIN1,LPL,SREBF1
WP2197	Endothelin pathways	4	32	1.16	0.0035	9606.ENSP00000215832,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000384364	MAPK1,EDNRA,EDN1,NPY
WP3995	Prion disease pathway	4	32	1.16	0.0035	9606.ENSP00000215832,9606.ENSP00000322898,9606.ENSP00000381185,9606.ENSP00000393312	MAPK1,EBF1,BCL2,FGFR1
WP4149	White fat cell differentiation	4	32	1.16	0.0035	9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000477707	EBF1,STAT5A,SREBF1,NR1H3
WP1449	Regulation of toll-like receptor signaling pathway	7	139	0.76	0.0036	9606.ENSP00000215832,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412	MAPK1,CXCL10,CXCL11,CXCL9,IRAK4,MYD88,CCL5
WP3981	miRNA regulation of prostate cancer signaling pathways	4	33	1.14	0.0036	9606.ENSP00000215832,9606.ENSP00000346508,9606.ENSP00000363822,9606.ENSP00000381185	MAPK1,PDGFA,AR,BCL2
WP4155	Endometrial cancer	5	63	0.96	0.0036	9606.ENSP00000215832,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000393312	MAPK1,APC,CDH1,PTEN,FGFR1
WP4540	Hippo signaling regulation pathways	6	98	0.85	0.0036	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000306124,9606.ENSP00000346148,9606.ENSP00000393312,9606.ENSP00000400175	CDH1,IGF1R,PRKCE,PRKAA1,FGFR1,RHOA
WP4838	Regucalcin in proximal tubule epithelial kidney cells	4	33	1.14	0.0036	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000351908,9606.ENSP00000380365	MAPK1,TGFB1,MAP3K5,RGN
WP5083	Neuroinflammation and glutamatergic signaling	7	140	0.76	0.0036	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000414303	MAPK1,TGFB1,IFNG,CNTF,BCL2,LTA,BDNF
WP3679	Cell-type dependent selectivity of CCK2R signaling	3	13	1.42	0.0038	9606.ENSP00000226279,9606.ENSP00000358513,9606.ENSP00000419313	CD38,CNR1,TRPC1
WP4484	Control of immune tolerance by vasoactive intestinal peptide	3	13	1.42	0.0038	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000356213	TGFB1,IFNG,VIP
WP2374	Oncostatin M signaling pathway	5	65	0.95	0.0039	9606.ENSP00000215832,9606.ENSP00000266085,9606.ENSP00000306124,9606.ENSP00000371067,9606.ENSP00000478570	MAPK1,TIMP3,PRKCE,JAK2,VEGFA
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	5	66	0.94	0.0041	9606.ENSP00000221930,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	TGFB1,CXCL10,CXCL11,CXCL9,CCL5
WP3942	PPAR signaling pathway	5	67	0.93	0.0043	9606.ENSP00000256104,9606.ENSP00000278840,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000477707	FABP4,FADS2,PLIN1,LPL,NR1H3
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	4	37	1.09	0.0045	9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000478570	ANGPT2,PTGS2,EDN1,VEGFA
WP619	Type II interferon signaling (IFNG)	4	37	1.09	0.0045	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000371067	IFNG,CXCL10,CXCL9,JAK2
WP1984	Integrated breast cancer pathway	7	151	0.73	0.0046	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,CDH1,ATM,PTEN,AR,BCL2,VEGFA
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	3	15	1.36	0.0047	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000363973	TGFB1,CDH1,ALPL
WP4321	Thermogenesis	6	108	0.81	0.0047	9606.ENSP00000300055,9606.ENSP00000337332,9606.ENSP00000346148,9606.ENSP00000351908,9606.ENSP00000358513,9606.ENSP00000393312	PLIN1,SIRT6,PRKAA1,MAP3K5,CNR1,FGFR1
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	4	38	1.08	0.0047	9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000414303	PTEN,JAK2,RHOA,BDNF
WP5124	Alzheimers disease	9	255	0.61	0.0048	9606.ENSP00000215832,9606.ENSP00000257430,9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000309757,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000418525	MAPK1,APC,NOX4,VDAC1,LPL,MAP3K5,PTGS2,NOX1,MME
WP2059	Alzheimers disease and miRNA effects	9	258	0.6	0.0051	9606.ENSP00000215832,9606.ENSP00000257430,9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000309757,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000418525	MAPK1,APC,NOX4,VDAC1,LPL,MAP3K5,PTGS2,NOX1,MME
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	5	72	0.9	0.0051	9606.ENSP00000216181,9606.ENSP00000221930,9606.ENSP00000352264,9606.ENSP00000356515,9606.ENSP00000418525	MYH9,TGFB1,CD2AP,UTRN,MME
WP127	IL-5 signaling pathway	4	40	1.06	0.0052	9606.ENSP00000215832,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185	MAPK1,STAT5A,JAK2,BCL2
WP2526	PDGF pathway	4	40	1.06	0.0052	9606.ENSP00000215832,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000400175	MAPK1,PDGFB,PDGFA,RHOA
WP2828	Bladder cancer	4	40	1.06	0.0052	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000478570	MAPK1,THBS1,CDH1,VEGFA
WP4698	Vitamin D-sensitive calcium signaling in depression	4	40	1.06	0.0052	9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000383232	G6PD,NFE2L2,BCL2,GGT1
WP4872	MAP3K1 role in promoting and blocking gonadal determination	3	16	1.33	0.0052	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000400175	MAPK1,SOX9,RHOA
WP4136	Fibrin complement receptor 3 signaling pathway	4	41	1.05	0.0053	9606.ENSP00000305651,9606.ENSP00000390651,9606.ENSP00000400175,9606.ENSP00000401399	CXCL10,IRAK4,RHOA,MYD88
WP2034	Leptin signaling pathway	5	75	0.88	0.0055	9606.ENSP00000215832,9606.ENSP00000346148,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000400175	MAPK1,PRKAA1,PTEN,JAK2,RHOA
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	3	17	1.31	0.0055	9606.ENSP00000215832,9606.ENSP00000346148,9606.ENSP00000351908	MAPK1,PRKAA1,MAP3K5
WP437	EGF/EGFR signaling pathway	7	162	0.7	0.0056	9606.ENSP00000215832,9606.ENSP00000311005,9606.ENSP00000339191,9606.ENSP00000339916,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067	MAPK1,MAPK7,CAV1,LIMK2,STAT5A,PTEN,JAK2
WP3929	Chemokine signaling pathway	7	164	0.69	0.0060	9606.ENSP00000215832,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412	MAPK1,CXCL10,CXCL11,CCL20,CXCL9,JAK2,CCL5
WP4787	Osteoblast differentiation and related diseases	6	118	0.77	0.0060	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000306124,9606.ENSP00000311005,9606.ENSP00000368104,9606.ENSP00000393312	MAPK1,SOX9,PRKCE,MAPK7,BMP2,FGFR1
WP1971	Integrated cancer pathway	4	44	1.02	0.0061	9606.ENSP00000278616,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000381185	ATM,MAP3K5,PTEN,BCL2
WP2332	Interleukin-11 signaling pathway	4	44	1.02	0.0061	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000371067,9606.ENSP00000381185	MAPK1,TGFB1,JAK2,BCL2
WP3670	Interactions between LOXL4 and oxidative stress pathway	3	18	1.28	0.0061	9606.ENSP00000221930,9606.ENSP00000368104,9606.ENSP00000380252	TGFB1,BMP2,NFE2L2
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	3	18	1.28	0.0061	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000261769	MAPK1,TGFB1,CDH1
WP4823	Genes controlling nephrogenesis	4	44	1.02	0.0061	9606.ENSP00000330382,9606.ENSP00000352264,9606.ENSP00000478570,9606.ENSP00000480291	PDGFB,CD2AP,VEGFA,HNF1B
WP98	Prostaglandin synthesis and regulation	4	45	1.01	0.0064	9606.ENSP00000245479,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000368683	SOX9,EDNRA,PTGS2,EDN1
WP4478	LTF danger signal response pathway	3	19	1.26	0.0065	9606.ENSP00000215832,9606.ENSP00000390651,9606.ENSP00000401399	MAPK1,IRAK4,MYD88
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	4	46	1.0	0.0068	9606.ENSP00000278840,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000477707	FADS2,SREBF1,ABCG1,NR1H3
WP2261	Glioblastoma signaling pathways	5	82	0.85	0.0070	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000393312	MAPK1,IGF1R,ATM,PTEN,FGFR1
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	3	20	1.24	0.0072	9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000381185	ATM,PTEN,BCL2
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	3	20	1.24	0.0072	9606.ENSP00000346148,9606.ENSP00000380252,9606.ENSP00000478570	PRKAA1,NFE2L2,VEGFA
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	4	49	0.97	0.0080	9606.ENSP00000215832,9606.ENSP00000346148,9606.ENSP00000361021,9606.ENSP00000414303	MAPK1,PRKAA1,PTEN,BDNF
WP5111	Familial hyperlipidemia type 4	3	21	1.22	0.0080	9606.ENSP00000200676,9606.ENSP00000264717,9606.ENSP00000309757	CETP,GCKR,LPL
WP3611	Photodynamic therapy-induced AP-1 survival signaling.	4	50	0.96	0.0085	9606.ENSP00000229135,9606.ENSP00000351908,9606.ENSP00000380252,9606.ENSP00000381185	IFNG,MAP3K5,NFE2L2,BCL2
WP138	Androgen receptor signaling pathway	5	88	0.82	0.0088	9606.ENSP00000339191,9606.ENSP00000339916,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000400175	CAV1,LIMK2,PTEN,AR,RHOA
WP1584	Type II diabetes mellitus	3	22	1.2	0.0088	9606.ENSP00000215832,9606.ENSP00000345708,9606.ENSP00000401720	MAPK1,KCNJ11,GK
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	5	88	0.82	0.0088	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000426809	TGFB1,IFNG,SOX9,CD34,PROM1
WP363	Wnt signaling pathway	4	51	0.96	0.0088	9606.ENSP00000215832,9606.ENSP00000257430,9606.ENSP00000264717,9606.ENSP00000400175	MAPK1,APC,GCKR,RHOA
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	3	22	1.2	0.0088	9606.ENSP00000216862,9606.ENSP00000363973,9606.ENSP00000369442	CYP24A1,ALPL,KL
WP4747	Netrin-UNC5B signaling pathway	4	52	0.95	0.0092	9606.ENSP00000215832,9606.ENSP00000334329,9606.ENSP00000363973,9606.ENSP00000400175	MAPK1,UNC5B,ALPL,RHOA
WP262	Ebstein-Barr virus LMP1 signaling	3	23	1.18	0.0093	9606.ENSP00000215832,9606.ENSP00000351671,9606.ENSP00000474412	MAPK1,CCL20,CCL5
WP2355	Corticotropin-releasing hormone signaling pathway	5	91	0.8	0.0095	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000351908,9606.ENSP00000381185,9606.ENSP00000400175	MAPK1,TGFB1,MAP3K5,BCL2,RHOA
WP2795	Cardiac hypertrophic response	4	54	0.93	0.0101	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000311005,9606.ENSP00000383364	MAPK1,TGFB1,MAPK7,PLA2G2A
WP560	TGF-beta receptor signaling	4	54	0.93	0.0101	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000364683	TGFB1,IFNG,THBS1,BAMBI
WP2853	Endoderm differentiation	6	140	0.69	0.0106	9606.ENSP00000221930,9606.ENSP00000257430,9606.ENSP00000258341,9606.ENSP00000284031,9606.ENSP00000302630,9606.ENSP00000480291	TGFB1,APC,LAMC1,DDAH1,ONECUT1,HNF1B
WP4746	Thyroid hormones production and peripheral downstream signaling effects	5	94	0.79	0.0106	9606.ENSP00000215832,9606.ENSP00000300055,9606.ENSP00000337332,9606.ENSP00000384364,9606.ENSP00000393312	MAPK1,PLIN1,SIRT6,NPY,FGFR1
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	4	55	0.92	0.0106	9606.ENSP00000221930,9606.ENSP00000257430,9606.ENSP00000348069,9606.ENSP00000368104	TGFB1,APC,SREBF1,BMP2
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	3	25	1.14	0.0108	9606.ENSP00000215832,9606.ENSP00000314897,9606.ENSP00000419422	MAPK1,ANGPT2,AGTR1
WP2884	NRF2 pathway	6	143	0.68	0.0114	9606.ENSP00000221930,9606.ENSP00000330382,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000383232	TGFB1,PDGFB,TXN,G6PD,NFE2L2,GGT1
WP2806	Complement system	5	97	0.77	0.0115	9606.ENSP00000258341,9606.ENSP00000260356,9606.ENSP00000363641,9606.ENSP00000378046,9606.ENSP00000384957	LAMC1,THBS1,TXN,FKBP2,F11
WP167	Eicosanoid synthesis	3	26	1.12	0.0117	9606.ENSP00000356438,9606.ENSP00000383232,9606.ENSP00000383364	PTGS2,GGT1,PLA2G2A
WP530	Cytokines and inflammatory response	3	26	1.12	0.0117	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000346508	TGFB1,IFNG,PDGFA
WP4186	Somatroph axis (GH) and its relationship to dietary restriction and aging	2	6	1.58	0.0118	9606.ENSP00000268035,9606.ENSP00000361021	IGF1R,PTEN
WP455	GPCRs, class A rhodopsin-like	8	255	0.56	0.0118	9606.ENSP00000246553,9606.ENSP00000292303,9606.ENSP00000304767,9606.ENSP00000315011,9606.ENSP00000358513,9606.ENSP00000363596,9606.ENSP00000419422,9606.ENSP00000475344	FFAR1,CCR5,P2RY1,EDNRA,CNR1,CNR2,AGTR1,APLNR
WP4586	Metabolism of alpha-linolenic acid	2	6	1.58	0.0118	9606.ENSP00000278840,9606.ENSP00000356438	FADS2,PTGS2
WP4816	TGF-beta receptor signaling in skeletal dysplasias	4	58	0.9	0.0118	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000364683	TGFB1,IFNG,THBS1,BAMBI
WP3594	Circadian rhythm genes	7	199	0.61	0.0119	9606.ENSP00000285407,9606.ENSP00000346148,9606.ENSP00000348069,9606.ENSP00000349860,9606.ENSP00000361021,9606.ENSP00000477707,9606.ENSP00000480291	KLF10,PRKAA1,SREBF1,GFPT1,PTEN,NR1H3,HNF1B
WP304	Kit receptor signaling pathway	4	59	0.89	0.0120	9606.ENSP00000215832,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185	MAPK1,STAT5A,JAK2,BCL2
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	3	27	1.11	0.0120	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000368104	MAPK1,SOX9,BMP2
WP51	Regulation of actin cytoskeleton	6	149	0.67	0.0126	9606.ENSP00000215832,9606.ENSP00000257430,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000393312,9606.ENSP00000400175	MAPK1,APC,PDGFB,PDGFA,FGFR1,RHOA
WP3869	Cannabinoid receptor signaling	3	29	1.08	0.0142	9606.ENSP00000215832,9606.ENSP00000358513,9606.ENSP00000363596	MAPK1,CNR1,CNR2
WP4262	Breast cancer pathway	6	153	0.65	0.0142	9606.ENSP00000215832,9606.ENSP00000257430,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000393312	MAPK1,APC,IGF1R,ATM,PTEN,FGFR1
WP4494	Selective expression of chemokine receptors during T-cell polarization	3	29	1.08	0.0142	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000292303	TGFB1,IFNG,CCR5
WP4396	Nonalcoholic fatty liver disease	6	155	0.65	0.0148	9606.ENSP00000221930,9606.ENSP00000263774,9606.ENSP00000346148,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000477707	TGFB1,NDUFS3,PRKAA1,SREBF1,MAP3K5,NR1H3
WP2870	Extracellular vesicle-mediated signaling in recipient cells	3	30	1.06	0.0151	9606.ENSP00000221930,9606.ENSP00000257430,9606.ENSP00000426809	TGFB1,APC,PROM1
WP453	Inflammatory response pathway	3	30	1.06	0.0151	9606.ENSP00000229135,9606.ENSP00000258341,9606.ENSP00000260356	IFNG,LAMC1,THBS1
WP4561	Cell migration and invasion through p75NTR	3	30	1.06	0.0151	9606.ENSP00000360997,9606.ENSP00000400175,9606.ENSP00000414303	ADAMTS13,RHOA,BDNF
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	3	31	1.05	0.0161	9606.ENSP00000222305,9606.ENSP00000339191,9606.ENSP00000371067	USF2,CAV1,JAK2
WP3680	Physico-chemical features and toxicity-associated pathways	4	66	0.84	0.0161	9606.ENSP00000215832,9606.ENSP00000257430,9606.ENSP00000341208,9606.ENSP00000400175	MAPK1,APC,STAT5A,RHOA
WP3858	Toll-like receptor signaling related to MyD88	3	31	1.05	0.0161	9606.ENSP00000215832,9606.ENSP00000390651,9606.ENSP00000401399	MAPK1,IRAK4,MYD88
WP408	Oxidative stress response	3	32	1.03	0.0171	9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000380252	NOX4,NOX1,NFE2L2
WP176	Folate metabolism	4	69	0.82	0.0184	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000365777,9606.ENSP00000384906	MPO,IFNG,MTHFR,SAA1
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	4	69	0.82	0.0184	9606.ENSP00000309757,9606.ENSP00000346148,9606.ENSP00000348069,9606.ENSP00000360522	LPL,PRKAA1,SREBF1,RBP4
WP244	Alpha 6 beta 4 signaling pathway	3	33	1.02	0.0184	9606.ENSP00000215832,9606.ENSP00000258341,9606.ENSP00000400175	MAPK1,LAMC1,RHOA
WP299	Nuclear receptors in lipid metabolism and toxicity	3	33	1.02	0.0184	9606.ENSP00000216862,9606.ENSP00000354995,9606.ENSP00000477707	CYP24A1,ABCG1,NR1H3
WP4874	CAMKK2 pathway	3	33	1.02	0.0184	9606.ENSP00000215832,9606.ENSP00000226760,9606.ENSP00000380252	MAPK1,WFS1,NFE2L2
WP1589	Folate-alcohol and cancer pathway hypotheses	2	9	1.41	0.0188	9606.ENSP00000297785,9606.ENSP00000365777	ALDH1A1,MTHFR
WP3601	Lipid particles composition	2	9	1.41	0.0188	9606.ENSP00000200676,9606.ENSP00000309757	CETP,LPL
WP4241	Type 2 papillary renal cell carcinoma	3	34	1.01	0.0189	9606.ENSP00000221930,9606.ENSP00000330382,9606.ENSP00000478570	TGFB1,PDGFB,VEGFA
WP3584	MECP2 and associated Rett syndrome	4	72	0.81	0.0201	9606.ENSP00000268035,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000414303	IGF1R,SGK1,PTEN,BDNF
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	2	10	1.36	0.0218	9606.ENSP00000255409,9606.ENSP00000261769	CHI3L1,CDH1
WP2874	Liver X receptor pathway	2	10	1.36	0.0218	9606.ENSP00000348069,9606.ENSP00000477707	SREBF1,NR1H3
WP4707	Aspirin and miRNAs	2	10	1.36	0.0218	9606.ENSP00000356438,9606.ENSP00000478570	PTGS2,VEGFA
WP4331	Neovascularisation processes	3	37	0.97	0.0228	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000330382	MAPK1,TGFB1,PDGFB
WP170	Nuclear receptors	3	38	0.96	0.0243	9606.ENSP00000312987,9606.ENSP00000363822,9606.ENSP00000477707	HNF4A,AR,NR1H3
WP5049	Glycolysis in senescence	2	11	1.32	0.0248	9606.ENSP00000346148,9606.ENSP00000377192	PRKAA1,G6PD
WP4538	Regulatory circuits of the STAT3 signaling pathway	4	78	0.77	0.0251	9606.ENSP00000215832,9606.ENSP00000311005,9606.ENSP00000371067,9606.ENSP00000419422	MAPK1,MAPK7,JAK2,AGTR1
WP2877	Vitamin D receptor pathway	6	182	0.58	0.0264	9606.ENSP00000216862,9606.ENSP00000221930,9606.ENSP00000266085,9606.ENSP00000362057,9606.ENSP00000369442,9606.ENSP00000377192	CYP24A1,TGFB1,TIMP3,NOX1,KL,G6PD
WP4217	Ebola virus pathway in host	5	129	0.65	0.0275	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000331831,9606.ENSP00000339191,9606.ENSP00000400175	MAPK1,IGF1R,GAS6,CAV1,RHOA
WP49	IL-2 signaling pathway	3	42	0.91	0.0305	9606.ENSP00000215832,9606.ENSP00000341208,9606.ENSP00000381185	MAPK1,STAT5A,BCL2
WP5110	Familial hyperlipidemia type 3	2	13	1.25	0.0319	9606.ENSP00000200676,9606.ENSP00000309757	CETP,LPL
WP364	IL-6 signaling pathway	3	43	0.9	0.0320	9606.ENSP00000215832,9606.ENSP00000356213,9606.ENSP00000371067	MAPK1,VIP,JAK2
WP4018	Clear cell renal cell carcinoma pathways	4	85	0.73	0.0322	9606.ENSP00000221930,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000478570	TGFB1,PDGFB,PTEN,VEGFA
WP1591	Heart development	3	44	0.89	0.0335	9606.ENSP00000215832,9606.ENSP00000368104,9606.ENSP00000478570	MAPK1,BMP2,VEGFA
WP4263	Pancreatic adenocarcinoma pathway	4	87	0.72	0.0343	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,TGFB1,RHOA,VEGFA
WP4758	Nephrotic syndrome	3	45	0.88	0.0351	9606.ENSP00000216181,9606.ENSP00000317674,9606.ENSP00000352264	MYH9,APOL1,CD2AP
WP5112	Familial hyperlipidemia type 5	2	14	1.22	0.0351	9606.ENSP00000200676,9606.ENSP00000309757	CETP,LPL
WP69	T-cell receptor (TCR) signaling pathway	4	89	0.71	0.0363	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000292303,9606.ENSP00000354782	MAPK1,TGFB1,CCR5,CD247
WP2873	Aryl hydrocarbon receptor pathway	3	46	0.88	0.0364	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000380252	TGFB1,IFNG,NFE2L2
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	3	46	0.88	0.0364	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000400175	MAPK1,TGFB1,RHOA
WP117	GPCRs, other	4	90	0.71	0.0370	9606.ENSP00000292303,9606.ENSP00000315011,9606.ENSP00000358513,9606.ENSP00000445772	CCR5,EDNRA,CNR1,LTB4R2
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	3	47	0.87	0.0378	9606.ENSP00000215832,9606.ENSP00000341208,9606.ENSP00000371067	MAPK1,STAT5A,JAK2
WP2637	Interleukin-1 (IL-1) structural pathway	3	47	0.87	0.0378	9606.ENSP00000215832,9606.ENSP00000390651,9606.ENSP00000401399	MAPK1,IRAK4,MYD88
WP3644	NAD+ metabolism	2	15	1.19	0.0378	9606.ENSP00000226279,9606.ENSP00000337332	CD38,SIRT6
WP3853	ERK pathway in Huntingtons disease	2	15	1.19	0.0378	9606.ENSP00000215832,9606.ENSP00000414303	MAPK1,BDNF
WP231	TNF-alpha signaling pathway	4	92	0.7	0.0386	9606.ENSP00000215832,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000363641	MAPK1,MAP3K5,NOX1,TXN
WP2857	Mesodermal commitment pathway	5	145	0.6	0.0390	9606.ENSP00000284031,9606.ENSP00000312987,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000393312	DDAH1,HNF4A,JAK2,NFE2L2,FGFR1
WP3646	Hepatitis C and hepatocellular carcinoma	3	49	0.85	0.0406	9606.ENSP00000221930,9606.ENSP00000356438,9606.ENSP00000478570	TGFB1,PTGS2,VEGFA
WP3413	NOTCH1 regulation of endothelial cell calcification	2	16	1.16	0.0409	9606.ENSP00000363973,9606.ENSP00000478570	ALPL,VEGFA
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	2	16	1.16	0.0409	9606.ENSP00000200676,9606.ENSP00000309757	CETP,LPL
WP4962	Airway smooth muscle cell contraction	2	16	1.16	0.0409	9606.ENSP00000226279,9606.ENSP00000400175	CD38,RHOA
WP5109	Familial hyperlipidemia type 2	2	16	1.16	0.0409	9606.ENSP00000200676,9606.ENSP00000309757	CETP,LPL
WP4658	Small cell lung cancer	4	95	0.69	0.0411	9606.ENSP00000258341,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185	LAMC1,PTGS2,PTEN,BCL2
WP22	IL-9 signaling pathway	2	17	1.13	0.0441	9606.ENSP00000215832,9606.ENSP00000341208	MAPK1,STAT5A
WP3874	Canonical and non-canonical TGF-B signaling	2	17	1.13	0.0441	9606.ENSP00000221930,9606.ENSP00000478319	TGFB1,GREM1
WP4462	Platelet-mediated interactions with vascular and circulating cells	2	17	1.13	0.0441	9606.ENSP00000221930,9606.ENSP00000474412	TGFB1,CCL5
WP5108	Familial  hyperlipidemia type 1	2	17	1.13	0.0441	9606.ENSP00000200676,9606.ENSP00000309757	CETP,LPL
WP554	ACE inhibitor pathway	2	17	1.13	0.0441	9606.ENSP00000221930,9606.ENSP00000419422	TGFB1,AGTR1
WP185	Integrin-mediated cell adhesion	4	100	0.66	0.0467	9606.ENSP00000215832,9606.ENSP00000311005,9606.ENSP00000339191,9606.ENSP00000375844	MAPK1,MAPK7,CAV1,CAPN10
WP2064	Neural crest differentiation	4	100	0.66	0.0467	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000393312,9606.ENSP00000484631	SOX9,CDH1,FGFR1,PMP22
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	3	53	0.81	0.0467	9606.ENSP00000215832,9606.ENSP00000248553,9606.ENSP00000260356	MAPK1,HSPB1,THBS1
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	2	18	1.11	0.0467	9606.ENSP00000248553,9606.ENSP00000361021	HSPB1,PTEN
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	5	155	0.57	0.0467	9606.ENSP00000356729,9606.ENSP00000363822,9606.ENSP00000385834,9606.ENSP00000414303,9606.ENSP00000478570	FMO3,AR,TF,BDNF,VEGFA
WP195	IL-1 signaling pathway	3	54	0.81	0.0477	9606.ENSP00000215832,9606.ENSP00000390651,9606.ENSP00000401399	MAPK1,IRAK4,MYD88
WP2849	Hematopoietic stem cell differentiation	3	54	0.81	0.0477	9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000483018	CD34,STAT5A,ABO
WP395	IL-4 signaling pathway	3	54	0.81	0.0477	9606.ENSP00000215832,9606.ENSP00000341208,9606.ENSP00000371067	MAPK1,STAT5A,JAK2
WP1742	TP53 network	2	19	1.08	0.0499	9606.ENSP00000278616,9606.ENSP00000381185	ATM,BCL2
WP247	Small ligand GPCRs	2	19	1.08	0.0499	9606.ENSP00000358513,9606.ENSP00000363596	CNR1,CNR2
WP3287	Overview of nanoparticle effects	2	19	1.08	0.0499	9606.ENSP00000356438,9606.ENSP00000381185	PTGS2,BCL2
WP516	Hypertrophy model	2	19	1.08	0.0499	9606.ENSP00000229135,9606.ENSP00000478570	IFNG,VEGFA
